Found: 10
Select item for more details and to access through your institution.
Impact of selection bias on the evaluation of clusters of chemical compounds in the drug discovery process.
- Published in:
- Pharmaceutical Statistics, 2015, v. 14, n. 2, p. 129, doi. 10.1002/pst.1665
- By:
- Publication type:
- Article
Likelihood approach for evaluating bioequivalence of highly variable drugs.
- Published in:
- Pharmaceutical Statistics, 2015, v. 14, n. 2, p. 82, doi. 10.1002/pst.1661
- By:
- Publication type:
- Article
Dose finding with continuous outcome in phase I oncology trials.
- Published in:
- Pharmaceutical Statistics, 2015, v. 14, n. 2, p. 102, doi. 10.1002/pst.1662
- By:
- Publication type:
- Article
Validation of qualitative microbiological test methods.
- Published in:
- Pharmaceutical Statistics, 2015, v. 14, n. 2, p. 120, doi. 10.1002/pst.1663
- By:
- Publication type:
- Article
The analysis of incontinence episodes and other count data in patients with overactive bladder by Poisson and negative binomial regression.
- Published in:
- Pharmaceutical Statistics, 2015, v. 14, n. 2, p. 151, doi. 10.1002/pst.1664
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- 2015
- Publication type:
- Other
Exact calculation of power and sample size in bioequivalence studies using two one-sided tests.
- Published in:
- Pharmaceutical Statistics, 2015, v. 14, n. 2, p. 95, doi. 10.1002/pst.1666
- By:
- Publication type:
- Article
Phase I trial design for drug combinations with Bayesian model averaging.
- Published in:
- Pharmaceutical Statistics, 2015, v. 14, n. 2, p. 108, doi. 10.1002/pst.1668
- By:
- Publication type:
- Article
Viewpoint: model selection uncertainty, pre-specification, and model averaging.
- Published in:
- Pharmaceutical Statistics, 2015, v. 14, n. 2, p. 79, doi. 10.1002/pst.1671
- By:
- Publication type:
- Article
How to test hypotheses if you must.
- Published in:
- Pharmaceutical Statistics, 2015, v. 14, n. 2, p. 139, doi. 10.1002/pst.1667
- By:
- Publication type:
- Article